SCHEMBL4523959

SCHEMBL4523959

CCOC(=O)c1ccc(N2CCN(CCC3CCN(C(=O)OC(C)(C)C)CC3)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 12/20 0.56
HTR1A P08908 1/20 0.50
DRD2 P14416 1/20 0.50
HTR2A P28223 1/20 0.50
DRD3 P35462 1/20 0.50
NPSR1 Q6W5P4 2/20 0.48
MAPT P10636 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
TGFBR1 P36897 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505636 0.89 GPR119 (0.56) GPR119HTR1ADRD2HTR2ADRD3
SCHEMBL4504053 0.88 GPR119 (0.60) GPR119DRD2DRD3NPSR1MAPT
SCHEMBL4509537 0.88 ALDH1A1 (0.53) HTR1ADRD2HTR2ADRD3MAPT
SCHEMBL4515782 0.87 GPR119 (0.74) GPR119NPSR1MAPTMEN1KMT2A
SCHEMBL1742370 0.86 SMN1; SMN2 (0.60) GPR119NPSR1MAPTMEN1KMT2A
SCHEMBL8473421 0.85 GPR119 (0.53) GPR119HTR1ADRD2HTR2ADRD3
SCHEMBL7366692 0.85 GPR119 (0.59) GPR119DRD2DRD3MAPTALDH1A1
SCHEMBL4511011 0.85 GPR119 (0.59) GPR119NPSR1MAPTMEN1KMT2A
SCHEMBL4516799 0.85 ABL1 (0.58) GPR119MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL7368822 0.85 GPR119 (0.52) GPR119HTR1ADRD2HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed
EP-1909791-A1 G-PROTEIN COUPLED RECEPTOR AGONISTS Prosidion Limited (GB) 2008-04-16 EP disclosed
WO-2007003964-A1 G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203676-A1 G-protein Coupled Receptor Agonists GPR119, GCGR, GPBAR1 GPR119 1/4885HTR1A 266/4885DRD2 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.